Australia markets closed

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
16.30-0.18 (-1.09%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 18.23B
Enterprise value 20.55B
Trailing P/E 16.71
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.47
Price/book (mrq)1.58
Enterprise value/revenue 1.66
Enterprise value/EBITDA 101.02

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-23.70%
S&P500 52-week change 328.04%
52-week high 323.30
52-week low 314.15
50-day moving average 316.92
200-day moving average 317.29

Share statistics

Avg vol (3-month) 36.69M
Avg vol (10-day) 35.37M
Shares outstanding 51.11B
Implied shares outstanding 61.11B
Float 8435.23M
% held by insiders 159.26%
% held by institutions 14.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 45.83%
Trailing annual dividend rate 30.13
Trailing annual dividend yield 30.76%
5-year average dividend yield 44.87
Payout ratio 431.06%
Dividend date 3N/A
Ex-dividend date 410 Aug 2023
Last split factor 21.3:1
Last split date 319 Aug 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.18%
Operating margin (ttm)9.28%

Management effectiveness

Return on assets (ttm)2.16%
Return on equity (ttm)-1.63%

Income statement

Revenue (ttm)12.37B
Revenue per share (ttm)11.20
Quarterly revenue growth (yoy)-24.90%
Gross profit (ttm)N/A
EBITDA 1.15B
Net income avi to common (ttm)-22.28M
Diluted EPS (ttm)-0.02
Quarterly earnings growth (yoy)-75.00%

Balance sheet

Total cash (mrq)1.37B
Total cash per share (mrq)1.24
Total debt (mrq)3.82B
Total debt/equity (mrq)33.73%
Current ratio (mrq)1.26
Book value per share (mrq)10.46

Cash flow statement

Operating cash flow (ttm)-34.48M
Levered free cash flow (ttm)-235.19M